The new leadership moves, who’s behind them, and what they mean — delivered to your inbox every week. No credit card, unsubscribe anytime.
Weekly Digest
New leadership moves, summarized for you
Straight to Inbox
No login, no app to check — it comes to you
Leadership Trends
See who's moving and how much in your market
No credit card required Weekly executive digest
Obsidian Appoints Jeffrey Trigilio As Chief Financial Officer
RECENTLY ACQUIREDApr 15, 2024•about 2 years ago
Position
Chief Financial And Operations Officer
Company
Obsidian Therapeutics
Jeffrey Trigilio
CambridgeBiotechnologyHealth Care
Description
Obsidian Therapeutics, Inc. has announced the appointment of Jeffrey Trigilio as Chief Financial Officer, effective May 1, 2024.
Company Information
Company
Obsidian Therapeutics
Location
1030 Massachusetts Avenue, Suite 400
Cambridge, Massachusetts, United States
About
Obsidian Therapeutics, Inc. is a clinical biotechnology company pioneering engineered cell and gene therapies to deliver transformative outcomes for patients with intractable diseases. Obsidian’s proprietary cytoDRiVE® technology provides a way to precisely control the timing and level of protein function by using FDA approved small molecules. Obsidian is headquartered in Cambridge, Mass. The Company has collaborations with Bristol Myers Squibb and Vertex Pharmaceuticals. For more information, please visit www.obsidiantx.com and follow us on LinkedIn and Twitter.
CambridgeBiotechnologyHealth Care